Health

Several former students of Stone Academy, a now-shuttered for-profit nursing school in Connecticut, have filed a federal lawsuit against two state agencies. The lawsuit alleges that Connecticut’s Office of Higher Education (OHE) and Department of Public Health (DPH) invalidated their course credits, withheld licenses, and damaged their professional reputations. This legal action comes after the
0 Comments
The long-term effects of COVID-19 on the health of children have been a topic of concern and speculation since the beginning of the pandemic. However, a recent prospective Canadian study challenges the notion that children are significantly impacted by post-COVID-19 conditions (PCCs) defined by the World Health Organization (WHO). The study, conducted by Stephen Freedman,
0 Comments
Ischemic stroke is a leading cause of morbidity and mortality worldwide. Current guidelines recommend dual antiplatelet therapy (DAPT) within a 24-hour time window and for patients with minimal stroke symptoms. However, the INSPIRES trial suggests that the benefits of DAPT may extend beyond these parameters. In this article, we will critically analyze the trial’s findings
0 Comments
Febrile urinary tract infections (UTIs) in children have long been treated with a standard 10-day course of oral antibiotics. However, a recent randomized controlled trial called STOP challenges this conventional wisdom. The study found that a shorter course of antibiotics, lasting only five days, was just as effective in treating febrile UTIs in children. This
0 Comments
In April, we shed light on the alarming dangers associated with Brazilian butt lifts (BBLs) and the reasons behind South Florida’s status as a hotspot for BBL-related deaths. Since then, significant steps have been taken by plastic surgeons and Florida’s medical board to address the safety concerns surrounding this risky procedure. This article delves into
0 Comments
In a groundbreaking development, the FDA has recently granted approval for Eplontersen (Wainua) to treat polyneuropathy associated with hereditary transthyretin-mediated amyloidosis (ATTR) in adults. This remarkable achievement has been announced by Ionis Pharmaceuticals and AstraZeneca, paving the way for a potential breakthrough in treating this debilitating condition. Hereditary ATTR is a genetic disorder caused by
0 Comments
Cancer research and development have always been at the forefront of medical advancements. With each new finding, the hope of finding effective treatments and improving patient outcomes increases. However, it is important to critically analyze the latest cancer news to understand the significance and potential implications. In this article, we will examine several recent developments
0 Comments